TD Waterhouse Canada »

Nurix Therapeutics shares owned by TD Waterhouse Canada

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by TD Waterhouse Canada from 13F filings

Historical chart of TD Waterhouse Canada investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by TD Waterhouse Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by TD Waterhouse Canada

Quarter filed Position value Share count Share price at filing
2024-09-30 $6.2k 282 22.06

More positions owned by TD Waterhouse Canada

Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
Microsoft Corporation (MSFT)
Apple (AAPL)
Enbridge (ENB)
Bank Of Montreal Cadcom (BMO)
Manulife Finl Corp (MFC)
Tc Energy Corp (TRP)
Canadian Natural Resources (CNQ)
Canadian Natl Ry (CNI)
Brookfield Corp Cl A Ltd Vt Sh (BN)
JPMorgan Chase & Co. (JPM)
Fortis (FTS)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for TD Waterhouse Canada

Top funds holding Nurix Therapeutics

BlackRock
Redmile Group
Baker Bros. Advisors
T. Rowe Price Associates
T. Rowe Price Investment Management
ARK Investment Management
Pictet Asset Management Holding SA
Commodore Capital
Citadel Advisors
Geode Capital Management
Driehaus Capital Management
Affinity Asset Advisors
Deutsche Bank Aktiengesellschaft
Daniel D. Thurber
Samlyn Capital

View all funds holding Nurix Therapeutics